UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A novel synonymous variant in the F8 gene, p.(Leu40=)/c.120C>A, likely causes mild haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-07, Vol.24 (4), p.e289-e292

2018

Volltextzugriff (PDF)

Identification and characterization of an adenine to guanine transition within intron 10 of the factor VIII gene as a causative mutation in a patient with mild haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-01, Vol.19 (1), p.100-105

2013

Volltextzugriff (PDF)

Ten-year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-05, Vol.21 (3), p.374-379

2015

Volltextzugriff (PDF)

A phase III clinical trial of a mixture agent of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-01, Vol.23 (1), p.59-66

2017

Volltextzugriff (PDF)

Usefulness of a simple self‐administered joint condition assessment sheet to predict the need for orthopaedic intervention in the management of haemophilic arthropathy

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-03, Vol.23 (2), p.e116-e123

2017

Volltextzugriff (PDF)

A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-11, Vol.19 (6), p.853-860

2013

Volltextzugriff (PDF)

Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors-phase I trial: 2nd report

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-03, Vol.19 (2), p.330-337

2013

Volltextzugriff (PDF)

Factor VIII haplotypes of Japanese population show similarity to those of Caucasian populations

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-03, Vol.18 (2), p.e43-e44

2012

Volltextzugriff (PDF)

An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-09, Vol.17 (5), p.771-776

2011

Volltextzugriff (PDF)

Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors - Phase I trial

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-01, Vol.18 (1), p.94-101

2012

Volltextzugriff (PDF)

Acute alveolar haemorrhage in a patient with haemophilia B

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-01, Vol.18 (1), p.e29-e31

2012

Volltextzugriff (PDF)

Clinical evaluation of recombinant factor VIII preparation (Kogenate) in previously treated patients with Hemophilia A : Descriptive meta-analysis of post-marketing study data

International journal of hematology, 2006-08, Vol.84 (2), p.158-165

2006

Volltextzugriff (PDF)

Clinical evaluation of a recombinant factor VIII preparation (Kogenate) in previously untreated patients with hemophilia A

International journal of hematology, 2003-12, Vol.78 (5), p.467-474

2003

Volltextzugriff (PDF)

OC 12.1 First Evidence of Improvement of Long-term Joint Outcomes through Ultrasound for Hemophilia; from 3-Years Prospective J-DaUPHIN Study

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100441, Article 100441

2023

Volltextzugriff (PDF)

Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A

Thrombosis and haemostasis, 2017, Vol.117 (2), p.252-261

2017

Volltextzugriff (PDF)

PB0218 Trisomy X Conferring Moderate Hemophilia A by Extremely Skewed X-Chromosome Inactivation

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101276, Article 101276

2023

Volltextzugriff (PDF)

Inhibitor development, safety and efficacy of Advate® among previously treated patients with hemophilia A in a postmarketing surveillance in Japan

International journal of hematology, 2019-03, Vol.109 (3), p.336-345

2019

Volltextzugriff (PDF)

Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa

Journal of thrombosis and haemostasis, 2014-08, Vol.12 (8), p.1244-1253

2014

Volltextzugriff (PDF)

Hemophilia and related diseases

Nihon rinshō, 2001-11, Vol.59 Suppl 7, p.459

Fukutake, K

2001

Volltextzugriff (PDF)

Perioperative safety and hemostatic efficacy of Advate® in patients with hemophilia A in a postmarketing surveillance in Japan

International journal of hematology, 2018-07, Vol.108 (1), p.22-29

2018

Volltextzugriff (PDF)

Real-World Amount of Clotting Factor Concentrates Dispensed and Annual Medical Expenditures for Japanese Patients with Hemophilia B

Journal of blood medicine, 2023-01, Vol.14, p.649-661

2023

Volltextzugriff (PDF)

Polymorphism in RANTES Chemokine Promoter Affects HIV-1 Disease Progression

Proceedings of the National Academy of Sciences - PNAS, 1999-04, Vol.96 (8), p.4581-4585

1999

Volltextzugriff (PDF)

As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan

Thrombosis and haemostasis, 2011-05, Vol.105 (5), p.925-927

2011

Volltextzugriff (PDF)

Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan

Haemophilia : the official journal of the World Federation of Hemophilia, 2001-05, Vol.7 (3), p.242-249

2001

Volltextzugriff (PDF)

Spontaneous Extracranial Vertebral Artery Dissociation: A Case Report and Review of the Literature

Open journal of orthopedics, 2018, Vol.8 (6), p.221-226

2018

Volltextzugriff (PDF)

1 – 25 von 331

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(221)
Mit Volltextzugriff
(155)

Publikationsform

Sprache

Englisch
(200)
Japanisch
(136)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A novel synonymous variant in the F8 gene, p.(Leu40=)/c.120C>A, likely causes mild haemophilia A

Identification and characterization of an adenine to guanine transition within intron 10 of the factor VIII gene as a causative mutation in a patient with mild haemophilia A

Ten-year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan

A phase III clinical trial of a mixture agent of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors

Usefulness of a simple self‐administered joint condition assessment sheet to predict the need for orthopaedic intervention in the management of haemophilic arthropathy

A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics

Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors-phase I trial: 2nd report

Factor VIII haplotypes of Japanese population show similarity to those of Caucasian populations

An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan

Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors - Phase I trial

Acute alveolar haemorrhage in a patient with haemophilia B

Clinical evaluation of recombinant factor VIII preparation (Kogenate) in previously treated patients with Hemophilia A : Descriptive meta-analysis of post-marketing study data

Clinical evaluation of a recombinant factor VIII preparation (Kogenate) in previously untreated patients with hemophilia A

OC 12.1 First Evidence of Improvement of Long-term Joint Outcomes through Ultrasound for Hemophilia; from 3-Years Prospective J-DaUPHIN Study

Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A

PB0218 Trisomy X Conferring Moderate Hemophilia A by Extremely Skewed X-Chromosome Inactivation

Inhibitor development, safety and efficacy of Advate® among previously treated patients with hemophilia A in a postmarketing surveillance in Japan

Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa

Hemophilia and related diseases

Perioperative safety and hemostatic efficacy of Advate® in patients with hemophilia A in a postmarketing surveillance in Japan

Real-World Amount of Clotting Factor Concentrates Dispensed and Annual Medical Expenditures for Japanese Patients with Hemophilia B

Polymorphism in RANTES Chemokine Promoter Affects HIV-1 Disease Progression

As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan

Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan

Spontaneous Extracranial Vertebral Artery Dissociation: A Case Report and Review of the Literature

Suchergebnisse filtern